Clinical Trial: An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07037238) titled 'An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations' on May 27.

Brief Summary: This study is a single-arm exploratory trial conducted by Xuanwu Hospital, Capital Medical University, aiming to evaluate the efficacy and safety of everolimus monotherapy in adult patients with vascular malformations.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Vascular Malformations

Intervention: DRUG: Everolimus 10mg daily

An oral mTOR inhibitor

Recruitment Status: RECRUITING

Sponsor: Xuanwu Hospital, Beijing

Disclaimer: Curated by HT Syndication....